HAS-BLED score

There are 21 papers on HAS-BLED score in aging research: 1 trial and 18 observational studies in people, 1 review.

Biomarker

21 papers study it19 more mention it4 findings

3 new papers in 30 daysSee all 40 papers on HAS-BLED score

“HR 1.4 (95% CI: 1.3-1.5) for HAS-BLED 3+”
Association of CHA₂DS₂-VASc and HAS-BLED to frailty and frail outcomes: From the TREAT-AF studyAmerican heart journal2023doi:10.1016/j.ahj.2023.03.015
  • Human trial1
  • Humans18

Upstream

1

Bleeding complications

no changein humans1

1 study
  1. Bleeding complications were not clearly linked with HAS-BLED score in humans (patients with versus without bleeding complications during direct oral anticoagulant use).

    Humanspatients with versus without bleeding complications during direct oral anticoagulant usemean of 2.56 yearsn = 142

More on Bleeding complications

Associations

3

Noncardiovascular frail events

upin humans1HR 1.4

1 study
  1. HAS-BLED score is linked with a higher risk of noncardiovascular frail events in humans after adjusting for covariates in patients with AF (HR 1.4 (95% CI: 1.3-1.5)).

    Humansafter adjusting for covariates in patients with AF

Frailty

upin humans1OR 13.4

1 study
  1. HAS-BLED score is associated with frailty in patients with AF (OR 13.4 (10.2-17.5)).

    Humansin patients with AF

Intracerebral hemorrhage

upin humans1

1 study
  1. HAS-BLED score predicts intracerebral hemorrhage in humans (highest complexity level; HAS-BLED cut-off ≥3) (AUC 0.7).

    Humanshighest complexity level; HAS-BLED cut-off ≥3five years

More on Intracerebral hemorrhage

Latest

Dec 2025: 2Jan 2026: 0Feb 2026: 1Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 29 papers in 12 months

See all 40 papers on HAS-BLED score